Aursnes I - Search Results

1

Drug use during early pregnancy. The impact of maternal illness, outcome of prior pregnancies and socio-demographic factors.

Nordeng H, Eskild A, Nesheim BI, Aursnes I, Jacobsen G. Nordeng H, et al. Among authors: aursnes i. Eur J Clin Pharmacol. 2001 Jun;57(3):259-63. doi: 10.1007/s002280100304. Eur J Clin Pharmacol. 2001. PMID: 11497342

2

Guidelines for iron supplementation in pregnancy: compliance among 431 parous Scandinavian women.

Nordeng H, Eskild A, Nesheim BI, Aursnes I, Jacobsen G. Nordeng H, et al. Among authors: aursnes i. Eur J Clin Pharmacol. 2003 Jun;59(2):163-8. doi: 10.1007/s00228-003-0599-x. Epub 2003 May 7. Eur J Clin Pharmacol. 2003. PMID: 12734609

3

Does atenolol differ from other beta-adrenergic blockers?

Aursnes I, Osnes JB, Tvete IF, Gåsemyr J, Natvig B. Aursnes I, et al. BMC Clin Pharmacol. 2007 May 8;7:4. doi: 10.1186/1472-6904-7-4. BMC Clin Pharmacol. 2007. PMID: 17488499 Free PMC article.

4

Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).

Nguyen KN, Aursnes I, Kjekshus J. Nguyen KN, et al. Among authors: aursnes i. Am J Cardiol. 1997 Jan 15;79(2):115-9. doi: 10.1016/s0002-9149(96)00696-0. Am J Cardiol. 1997. PMID: 9193008 Clinical Trial.

5

Acute myocardial infarction mortality related to use of calcium antagonists before admission to hospital.

Landmark K, Reikvam A, Abdelnoor M, Sivertssen E, Aursnes I. Landmark K, et al. Among authors: aursnes i. Cardiovasc Drugs Ther. 1998 May;12(2):183-7. doi: 10.1023/a:1007783227823. Cardiovasc Drugs Ther. 1998. PMID: 9652877

6

Hospital mortality from acute myocardial infarction has been modestly reduced after introduction of thrombolytics and aspirin: results from a new analytical approach. European Secondary Prevention Study Group.

Reikvam A, Aursnes I. Reikvam A, et al. Among authors: aursnes i. J Clin Epidemiol. 1999 Jul;52(7):609-13. doi: 10.1016/s0895-4356(99)00042-6. J Clin Epidemiol. 1999. PMID: 10391653

7

Meta-regression analysis of paroxetine clinical trial data: does reporting scale matter?

Klemp M, Tvete IF, Gåsemyr J, Natvig B, Aursnes I. Klemp M, et al. Among authors: aursnes i. J Clin Psychopharmacol. 2011 Apr;31(2):201-6. doi: 10.1097/JCP.0b013e318210bac1. J Clin Psychopharmacol. 2011. PMID: 21346610

8

Association between various drugs used for hypertension and risk of acute myocardial infarction.

Aursnes I, Litleskare I, Frøyland H, Abdelnoor M. Aursnes I, et al. Blood Press. 1995 May;4(3):157-63. doi: 10.3109/08037059509077588. Blood Press. 1995. PMID: 7670649

9

Clinical efficacies of antihypertensive drugs.

Aursnes I, Tvete IF, Gåsemyr J, Natvig B. Aursnes I, et al. Scand Cardiovasc J. 2003 May;37(2):72-9. doi: 10.1080/14017430310001186. Scand Cardiovasc J. 2003. PMID: 12775305

10

Common adverse events associated with an SSRI: meta-analysis of early paroxetine data.

Aursnes I, Gjertsen MK. Aursnes I, et al. Pharmacoepidemiol Drug Saf. 2008 Jul;17(7):707-13. doi: 10.1002/pds.1596. Pharmacoepidemiol Drug Saf. 2008. PMID: 18383561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page